Loss of cellular K+ mimics ribotoxic stress. Inhibition of protein synthesis and activation of the stress kinases SEK1/MKK4, stress-activated protein kinase/c-Jun NH2-terminal kinase 1, and p38/HOG1 by palytoxin

Journal of Biological Chemistry

Volumn 273, Issue 6, 1998, Pages 3528-3534

  Iordanov, Mihail S ^a   Magun, Bruce E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); PALYTOXIN; POTASSIUM ION; PROTEIN KINASE C; SODIUM ION;

ANIMAL CELL; ARTICLE; COVALENT BOND; ENZYME ANALYSIS; NONHUMAN; OXIDATIVE STRESS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE DIAGNOSIS; RAT; TRANSLATION REGULATION;

ACRYLAMIDES; ANIMALS; CELL LINE; ENZYME ACTIVATION; ION TRANSPORT; POTASSIUM; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; PROTEIN SYNTHESIS INHIBITORS; RATS; RIBOSOMES;

EID: 0032488926     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.273.6.3528     Document Type: Article

References (51)

1. Iordanov, M. S., Pribnow, D., Magun, J. L., Dinh, T.-H., Pearson, J. A., Chen, S. L.-Y., and Magun, B. E. (1997) Mol. Cell. Biol. 17, 3373-3381
2. Fujiki, H., Suganuma, M., Tahira, T., Yoshioka, A., Nakayasu, M., Endo, Y., Shudo, K., Takayama, S., Moore, R. E., and Sugimura, T. (1983) Princess Takamatsu Symp. 14, 37-45
3. Fujiki, H., Suganuma, M., Nakayasu, M., Hakii, H., Horiuchi, T., Takayama, S., and Sugimura, T. (1986) Carcinogenesis 7, 707-710
4. Wattenberg, E. V., Uemura, D., Byron, K. L., Villereal, M. L., Fujiki, H., and Rosner, M. R. (1989) Cancer Res. 49, 5837-5842
5. Scribner, J. D., and Boutwell, R. K. (1972) Eur. J. Cancer 8, 617-621
6. Segal, A., Van Duuren, B. L., Mate, U., Solomon, J. J., Seidman, I., Smith, A., and Melchionne, S. (1978) Cancer Res. 38, 921-925
7. Fischer, S, M. (1980) Arachidonic Acid Metabolism and Tumor Promotion, Martinus Nijhoff, Boston
8. Furstenberger, G., Berry, D. L., Sorg, B., and Marks, F. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 7722-7726
9. McGaughey, C., and Jensen, J. L. (1983) J. Toxicol. Environ. Health 11, 467-474
10. Schoof, R. A., and Baxter, C. S. (1986) Int. J. Immunopharmacol. 8, 455-462
11. Lewis, J. G., and Adams, D. O. (1987) Carcinogenesis 8, 889-898
12. Michiel, D. F., and Oppenheim, J. J. (1992) Semin. Cancer Biol. 3, 3-15
13. Martins-Green, M., Boudreau, N., and Bissell, M. J. (1994) Cancer Res. 54, 4334-4341
14. Furstenberger, G., Csuk-Glanzer, B. I., Marks, F., and Keppler, D. (1994) Carcinogenesis 16, 2823-2827
15. Marks, F., Furstenberger, G., Heinzelmann, T., and Muller-Decker, K. (1995) Toxicol. Lett. 83, 907-917
16. Kyriakis, J. M., and Avruch, J. (1996) BioEssays 18, 567-577
17. Kuroki, D. W., Bignami, G. S., and Wattenberg, E. V. (1996) Cancer Res. 56, 637-644
18. Angel, P., and Karin, M. (1991) Biochim. Biophys. Acta 1072, 129-157
19. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993) Genes Dev. 7, 2135-2148
20. Derijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng. T., Karin, M., and Davis, R. J. (1994) Cell 76, 1025-1037
21. Whitmarsh, A. J., Shore, P., Sharrocks, A. D., and Davis, R. J. (1995) Science 269, 403-407
22. Cavigelli, M., Dolfi, F., Claret, F.-X., and Karin, M. (1995) EMBO J. 14, 5957-5964
23. Treisman, R. (1994) Curr. Opin. Genet. Dev. 4, 96-101
24. Treisman, R. (1995) EMBO J. 14, 4905-4913
25. Gupta, S., Campbell, D., Derijard, B., and Davis, R. J. (1995) Science 267, 389-393
26. van Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herrlich, P., and Angel, P. (1995) EMBO J. 14, 1798-1811
27. van Dam, H., Duyndam, M., Rottier, R., Bosch, A., de Vries-Smits, L., Herrlich, P., Zantema, A., Angel, P., and van der Eb, A. J. (1993) EMBO J. 12, 479-487
28. Habermann, E. (1989) Toxicon 27, 1171-1187
29. Scheiner-Bobis, G., Meyer zu Heringdorf, D., Christ, M., and Habermann, E. (1994) Mol. Pharmacol. 45, 1132-1136
30. Redondo, J., Fiedler, B., and Scheiner-Bobis, G. (1996) Mol. Pharmacol. 49, 49-57
31. Ohuchi, K., Watanabe, M., Yoshizawa, K., Tsurufuji, S., Fujiki, H., Suganuma, M., Sugimura, T., and Levine, L. (1985) Biochim. Biophys. Acta 834, 42-47
32. Levine, L., Xiao, D. M., and Fujiki, H. (1986) Prostaglandins 31, 669-681
33. Levine, L., Xiao, D., and Fujiki, H. (1986) Carcinogenesis 7, 99-103
34. Lazzaro, M., Tashjian, A., Jr., Fujiki, H., and Levine, L. (1987) Endocrinology 120, 1338-1345
35. Aizu, E., Yamamoto, S., Nakadate, T., and Kato, R. (1990) Eur. J. Pharmacol. 182, 19-28
36. Levine, L. (1991) Prostaglandins 41, 7-19
37. Wattenberg, E. V., Fujiki, H., and Rosner, M. R. (1987) Cancer Res. 47, 4618-4622
38. Wattenberg, E. V., McNeil, P. L., Fujiki, H., and Rosner, M. R. (1989) J. Biol. Chem. 264, 213-219
39. Wattenberg, E. V., Byron, K. L., Villereal, M. L., Fujiki, H., and Rosner. M. R. (1989) J. Biol. Chem. 264, 14668-14673
40. Rodrigues-Fonseca, C., Amils, R., and Garrett, R. A. (1995) J. Mol. Biol. 247, 224-235
41. Wool, I. G., Glück, A., and Endo, Y. (1992) Trends Biochem. Sci. 17, 266-269
42. VanBogelen, R., and Neidhardt, F. C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 5589-5593
43. Magun, B. E., and Rodland, K. D. (1995) Cell Growth Differ. 6, 891-897
44. Rodland, K., Wersto, R., Hobson, S., and Kohn, E. (1997) Mol. Endocrinol. 11, 281-291
45. Sanchez, I., Hughes, R. T., Mayer, B. J., Yee, K., Woodgett, J. R., Avruch, J., Kyriakis, J. M., and Zon, L. I. (1994) Nature 372, 794-798
46. Lin, A., Minden, A., Martinetto, H., Claret, F.-X., Lange-Carter, C., Mercurio, F., Johnson, G. L., and Karin, M. (1995) Science 268, 286-290
47. Derijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., and Davis, R. J. (1995) Science 267, 682-684
48. Yan, M., Dai, T., Deak, J. C., Kyriakis, J. M., Zon, L. I., Woodgett, J. R., and Templeton, D. J. (1994) Nature 372, 798-800
49. Pestka, S. (1971) Anna. Rev. Microbiol. 25, 487-562
50. Vazquez, D. (1979) Inhibitors of Protein Biosynthesis, Springer-Verlag, Berlin
51. Brotherus, J. R., Moller, J. V., and Jorgensen P. L. (1981) Biochem. Biophys. Res. Commun. 100, 146-154